Camden Property Trust (CPT) is a real estate investment trust (REIT) focused on the multifamily apartment sector in the United States, operating within the Real Estate sector's REIT - Residential industry. The company owns, manages, and develops apartment communities, with a portfolio of 174 properties and ongoing development projects. In its recent earnings history, CPT has shown a fluctuating performance against analyst expectations. For Q4 2025, the company reported actual EPS of $1.76 against an estimate of $0.3522, and actual revenue of $390.79 million against an estimate of $397.22 million, indicating a significant EPS beat but a revenue miss. This followed Q3 2025, where actual EPS was $0.21449 against an estimate of $0.27944, and actual revenue was $395.68 million (revenue estimate not provided), marking an EPS miss. Looking at the prior two quarters, Q2 2025 saw actual EPS of $0.3051 against an estimate of $0.32757 and actual revenue of $396.51 million (revenue estimate not provided), also an EPS miss. Q1 2025 reported actual EPS of $0.36 against an estimate of $0.27793 and actual revenue of $390.57 million (revenue estimate not provided), marking an EPS beat. This pattern reveals a mixed beat/miss record, with an EPS beat in Q1 and Q4 2025, but misses in Q2 and Q3 2025. Revenue estimates were not consistently available for direct comparison, but the actual revenue figures have remained relatively stable. The company has a history of strong performance, evidenced by its consistent recognition on Fortune's "100 Best Companies to Work For" list for 19 consecutive years, most recently ranking 13th. Recent news indicates that CPT shares have fallen to a 52-week low, accompanied by mixed analyst sentiment and price target adjustments, though some maintain outperform ratings. The company also announced a quarterly dividend increase. Investors will be watching for how the company's strong employer branding translates into operational advantages and whether future earnings reports can sustain the EPS beat seen in Q4 2025, especially given recent price weakness and mixed analyst views.
